CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$32.98
-0.43 (-1.29%)
Open$32.87
Previous Close$33.41
Day High$33.72
Day Low$32.57
52W High$35.79
52W Low$19.52
Volume—
Avg Volume997.0K
Market Cap2.55B
P/E Ratio—
EPS$-4.27
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+57.9% upside
Current
$32.98
$32.98
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.90M | 2.18M | 613.37M |
| Net Income | -317,124,929 | -328,702,563 | -4,777,656 |
| Profit Margin | -16,748.0% | -15,910.6% | -0.8% |
| EBITDA | -348,042,107 | -380,790,051 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | -13.2% | -13.2% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |